News

At Heart Rhythm 2014, panel of experts from three prominent medical groups share recommendations for patient populations not well represented in current guidelines The Heart Rhythm Society (HRS), American College of Cardiology (ACC) and...

Data Presented at Heart Rhythm Society Annual Meeting Support Plans for Phase 3 Development of a Fixed-Dose Combination of Ranolazine and Low-Dose Dronedarone in Atrial Fibrillation Patients Gilead Sciences, Inc. announced results from...

Late-breaking Clinical Trial Data Confirm Industry Leadership with 1 Percent Inappropriate Shocks Using Medtronic SmartShock Technology Medtronic, Inc. announced the results from the first prospective randomized clinical trial to show that...

Vivek Reddy, MD, of The Mount Sinai Hospital Presents 12-Month Follow-Up Study Results in Late-Breaking Clinical Trial Presentation at Heart Rhythm 2014 Vivek Reddy, MD, Director of Arrhythmia Services for The Mount Sinai Hospital, reported...

Comparative effectiveness study shows use of quadripolar technology reduces hospital utilization and lowers overall costs ST. PAUL, Minn. – May 9, 2014 – St. Jude Medical, Inc., a global medical device company, announced that data presented...

Boston Scientific Shockless Implant Evaluation (SIMPLE) Study Results Presented at Heart Rhythm 2014, the Heart Rhythm Society's 35th Annual Scientific Sessions A Boston Scientific Corporation study demonstrated that outcomes for patients...

Data presented during a Late Breaking Clinical Trial at Heart Rhythm 2014 is the industry’s largest study of remote management of pacemaker patients St. Jude Medical, Inc., a global medical device company, announced that data presented...

Late-Breaking Clinical Trial Data Show Implant Success with Pacing Inside the Left Ventricle in Heart Failure Patients Medtronic, Inc. released study findings that show heart failure patients who have limited options for implanted device...

St. Jude Medical, Inc., a global medical device company, announced results of the TOCCASTAR clinical trial at Heart Rhythm 2014, the Heart Rhythm Society’s 35th Annual Scientific Sessions in San Francisco. Results from the first prospective,...

New Device Automatically Adapts to Patient Needs, Continuously Optimizes Therapy, Improves Response Rate and Reduces Heart Failure Hospitalizations Medtronic, Inc. announced CE (Conformité Européenne) Mark receipt and the European launch of...